Identification of MicroRNA-21 as a Biomarker for Chemoresistance and Clinical Outcome Following Adjuvant Therapy in Resectable Pancreatic Cancer

J.H. Hwang; J. Voortman; E. Giovannetti; S.M. Steinberg; L.G. Leon; Y.T. Kim; N. Funel; J.K. Park; M.A. Kim; G.H. Kang; S.W. Kim; M. Del Chiaro; G.J. Peters; G. Giaccone

doi:10.1371/journal.pone.0010630

Identification of MicroRNA-21 as a Biomarker for Chemoresistance and Clinical Outcome Following Adjuvant Therapy in Resectable Pancreatic Cancer

J.H. Hwang, J. Voortman, E. Giovannetti, S.M. Steinberg, L.G. Leon, Y.T. Kim, N. Funel, J.K. Park, M.A. Kim, G.H. Kang, S.W. Kim, M. Del Chiaro, G.J. Peters, G. Giaccone

Research output: Contribution to journal › Article › Academic › peer-review

80 Downloads (Pure)

Original language	English
Article number	e10630
Pages (from-to)	e10630
Number of pages	12
Journal	PLoS ONE
Volume	5
Issue number	5
DOIs	https://doi.org/10.1371/journal.pone.0010630
Publication status	Published - 2010

Access to Document

10.1371/journal.pone.0010630

256803Final published version, 635 KB

Cite this

Hwang, J. H., Voortman, J., Giovannetti, E., Steinberg, S. M., Leon, L. G., Kim, Y. T., Funel, N., Park, J. K., Kim, M. A., Kang, G. H., Kim, S. W., Del Chiaro, M., Peters, G. J., & Giaccone, G. (2010). Identification of MicroRNA-21 as a Biomarker for Chemoresistance and Clinical Outcome Following Adjuvant Therapy in Resectable Pancreatic Cancer. PLoS ONE, 5(5), e10630. [e10630]. https://doi.org/10.1371/journal.pone.0010630

Hwang, J.H. ; Voortman, J. ; Giovannetti, E. ; Steinberg, S.M. ; Leon, L.G. ; Kim, Y.T. ; Funel, N. ; Park, J.K. ; Kim, M.A. ; Kang, G.H. ; Kim, S.W. ; Del Chiaro, M. ; Peters, G.J. ; Giaccone, G. / Identification of MicroRNA-21 as a Biomarker for Chemoresistance and Clinical Outcome Following Adjuvant Therapy in Resectable Pancreatic Cancer. In: PLoS ONE. 2010 ; Vol. 5, No. 5. pp. e10630.

@article{395c4790f76e41bb900555a897b80fc6,

title = "Identification of MicroRNA-21 as a Biomarker for Chemoresistance and Clinical Outcome Following Adjuvant Therapy in Resectable Pancreatic Cancer",

author = "J.H. Hwang and J. Voortman and E. Giovannetti and S.M. Steinberg and L.G. Leon and Y.T. Kim and N. Funel and J.K. Park and M.A. Kim and G.H. Kang and S.W. Kim and {Del Chiaro}, M. and G.J. Peters and G. Giaccone",

year = "2010",

doi = "10.1371/journal.pone.0010630",

language = "English",

volume = "5",

pages = "e10630",

journal = "PLoS ONE",

issn = "1932-6203",

publisher = "Public Library of Science",

number = "5",

}

Hwang, JH, Voortman, J , Giovannetti, E, Steinberg, SM, Leon, LG, Kim, YT, Funel, N, Park, JK, Kim, MA, Kang, GH, Kim, SW, Del Chiaro, M, Peters, GJ & Giaccone, G 2010, 'Identification of MicroRNA-21 as a Biomarker for Chemoresistance and Clinical Outcome Following Adjuvant Therapy in Resectable Pancreatic Cancer', PLoS ONE, vol. 5, no. 5, e10630, pp. e10630. https://doi.org/10.1371/journal.pone.0010630

Identification of MicroRNA-21 as a Biomarker for Chemoresistance and Clinical Outcome Following Adjuvant Therapy in Resectable Pancreatic Cancer. / Hwang, J.H.; Voortman, J.; Giovannetti, E.; Steinberg, S.M.; Leon, L.G.; Kim, Y.T.; Funel, N.; Park, J.K.; Kim, M.A.; Kang, G.H.; Kim, S.W.; Del Chiaro, M.; Peters, G.J.; Giaccone, G.

In: PLoS ONE, Vol. 5, No. 5, e10630, 2010, p. e10630.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Identification of MicroRNA-21 as a Biomarker for Chemoresistance and Clinical Outcome Following Adjuvant Therapy in Resectable Pancreatic Cancer

AU - Hwang, J.H.

AU - Voortman, J.

AU - Giovannetti, E.

AU - Steinberg, S.M.

AU - Leon, L.G.

AU - Kim, Y.T.

AU - Funel, N.

AU - Park, J.K.

AU - Kim, M.A.

AU - Kang, G.H.

AU - Kim, S.W.

AU - Del Chiaro, M.

AU - Peters, G.J.

AU - Giaccone, G.

PY - 2010

Y1 - 2010

U2 - 10.1371/journal.pone.0010630

DO - 10.1371/journal.pone.0010630

M3 - Article

C2 - 20498843

VL - 5

SP - e10630

JO - PLoS ONE

JF - PLoS ONE

SN - 1932-6203

IS - 5

M1 - e10630

ER -